top of page

Telefone: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Mashlo 2mg FlexTouch

Mashlo 2mg FlexTouch

Manufacturer/Marketed By : DR REDDY'S LABORATORIES LTD

$44.72 $40.25

Mashlo 2mg FlexTouch is a once-weekly injectable treatment used to support effective, sustained weight management in adults. It contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone that...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

SEMAGLUTIDE

Active Pharmaceutical Ingredient

Mashlo 2mg FlexTouch

SKU MASHLO-2MG-FLEXTOUCH
Preço original

US$ 44,72

Preço promocional

US$ 40,25

Mashlo 2mg FlexTouch is a once-weekly injectable treatment used to support effective, sustained weight management in adults. It contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone that regulates appetite and food intake. As part of modern GLP-1 weight-loss injections, Mashlo helps you feel full sooner and stay satisfied longer, supporting healthier eating habits. Because of this mechanism, Mashlo weight-loss outcomes are often more sustainable when combined with lifestyle changes, and many patients use Mashlo 2mg for weight loss under medical supervision. This treatment is commonly recommended for individuals who are overweight or living with obesity, particularly those who also have related conditions such as type 2 diabetes, high blood pressure, or high cholesterol. The Mashlo FlexTouch 2 mg, administered weekly, is determined by a healthcare professional based on individual response and tolerance. While Mashlo is effective, it is not a quick fix and should always be used as part of a long-term weight management plan that includes a balanced diet and regular physical activity. Before starting therapy, it is important to understand possible Mashlo  2mg side effects, which may include nausea, vomiting, diarrhoea, or digestive discomfort, especially during the initial weeks of treatment. Patients may also wish to discuss practical considerations such as the Mashlo 2mg price and treatment duration. Always consult your doctor, who will review your medical history and determine whether Mashlo is the right option for your weight management goals.

Active Pharmaceutical Ingredient

SEMAGLUTIDE

Usos

• Long-term weight management in adults with obesity (BMI of 30 or more)
• Weight management in adults with a BMI of 27 or more who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol

Benefícios

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Efeitos colaterais

Mashlo 2mg FlexTouch can cause side effects, as with any medication, although not everyone will experience them.

Efeitos colaterais mais comuns

• Severe stomach pain or signs of pancreatitis
• Gallbladder issues (like pain in your upper belly or yellowing of the skin)
• Signs of kidney problems (such as less urination or swelling)
• Fast heart rate
• Allergic reactions (rash, itching, swelling, trouble breathing)

Efeitos colaterais comuns

• Nausea
• Vomiting
• Constipation or diarrhoea
• Tiredness
• Headache
• Indigestion
• Bloating or gas

Como usar

Mashlo 2mg, a GLP-1–based medication, is given once a week as a subcutaneous injection. You can inject it into your stomach, thigh, or upper arm; just rotate injection sites to avoid irritation. It can be taken with or without food.

Conselhos de segurança

• Pregnancy: Mashlo 2mg FlexTouch is not safe during pregnancy. If you're planning to get pregnant, you'll need to stop this medication at least 2 months before trying.
• Breast Feeding: If you are breastfeeding, consult your healthcare provider before using Mashlo 2mg FlexTouch, as its efficacy and safety in breastfeeding are unknown.
• Lungs: Mashlo 2mg FlexTouch doesn’t directly affect your lungs. If you have asthma or another lung issue, it’s still safe, but your doctor should be in the loop.
• Liver: People with liver issues may still be able to take Mashlo 2mg FlexTouch, but some extra care and monitoring might be needed.
• Alcohol: Drinking alcohol while using Mashlo 2mg FlexTouch can increase your risk of stomach issues or low blood sugar, especially if you’re diabetic.
• Driving: Mashlo 2mg FlexTouch doesn’t usually affect your ability to drive. But if you feel dizzy, tired, or unwell after the shot, skip driving that day.

Isenção de responsabilidade

A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.

Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.

Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.

Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.

bottom of page